Prognosis of chronic Chagas heart disease and other pending clinical challenges

In this chapter, the main prognostic markers of Chagas heart disease are addressed, with an emphasis on the most recent findings and questions, establishing the basis for a broad discussion of recommendations and new approaches to managing Chagas cardiopathy. The main biological and genetic markers and the contribution of the electrocardiogram, echocardiogram and cardiac magnetic resonance are presented. We also discuss the most recent therapeutic proposals for heart failure, thromboembolism and arrhythmias, as well as current experience in heart transplantation in patients suffering from severe Chagas cardiomyopathy. The clinical and epidemiological challenges introduced by acute Chagas disease due to oral contamination are discussed. In addition, we highlight the importance of ageing and comorbidities in influencing the outcome of chronic Chagas heart disease. Finally, we discuss the importance of public policies, the vital role of funding agencies, universities, the scientific community and health professionals, and the application of new technologies in finding solutions for better management of Chagas heart disease.

The B-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi

BACKGROUND The infection led by Trypanosoma cruzi persists in mammalian tissues causing an inflammatory imbalance. Carvedilol (Cv), a non-selective beta blocker drug indicated to treat heart failure and antihypertensive has shown to promote antioxidant and immunomodulatory properties which might improve the inflammation induced by T. cruzi. OBJECTIVES Evaluate the role of Cv on the inflammatory response of C57BL/6 mice acutely infected with the Colombian strain of T. cruzi. METHODS Animals were infected with the Colombian strain of T. cruzi and treated with Cv (25 mg/kg/day), benznidazole (Bz) (100 mg/kg/day) or their combination. On the 28th day of infection and 23 days of treatment, the euthanasia occurred, and the heart preserved for histopathological, oxidative stress (SOD, catalase, TBARs, carbonylated proteins) and plasma (CCL2, CCL5, TNF, IL-10) analyses. Parasitaemia and survival were assessed along the infection. FINDINGS Cv decreased TBARs, but increased the mortality rate, the parasitaemia and the levels of CCL2, CCL5, catalase and the inflammatory infiltrate in the cardiac tissue. Bz led the reduction of the inflammatory infiltrate and circulating levels of oxidative stress and inflammatory mediators in the infected mice. MAIN CONCLUSIONS Our data suggest that Cv, in this experimental model using the Colombian strain of T. cruzi, caused damage to the host.

Influence of environmental enrichment on the behavior and physiology of mice infected by trypanosoma cruzi

Abstract INTRODUCTION: Enriched environments normally increase behavioral repertoires and diminish the expression of abnormal behaviors and stress-related physiological problems in animals. Although it has been shown that experimental animals infected with microorganisms can modify their behaviors and physiology, few studies have evaluated how environmental enrichment affects these parameters. This study aimed to evaluate the effects of environmental enrichment on the behavior and physiology of confined mice infected with Trypanosoma cruzi. METHODS: The behaviors of 20 T. cruzi-infected mice and 20 non-infected mice were recorded during three treatments: baseline, enrichment, and post-enrichment. Behavioral data were collected using scan sampling with instantaneous recording of behavior every 30s, totaling 360h. Plasma TNF, CCL2, and IL-10 levels and parasitemia were also evaluated in infected enriched/non-enriched mice. Behavioral data were evaluated by Friedman's test and physiological data by one-way ANOVA and area under the curve (AUC) analysis. RESULTS: Results showed that environmental enrichment significantly increased exploratory behaviors and diminished inactivity. The use of environmental enrichment did not diminish circulating levels of TNF and IL-10 but diminished circulating levels of CCL2 and parasitemia. CONCLUSIONS: Positive behavioral and physiological effects of environmental enrichment were observed in mice living in enriched cages. Thus, environmental enrichment improved the welfare of these animals.

Do Brazilian scientific journals promote the adherence of Chagas disease researchers to internacional ethical principals? / Periódicos científicos brasileiros promovem a adesão de pesquisadores em doença de Chagas a princípios éticos internacionais?

The ethical aspects of the Brazilian publications about human Chagas disease (CD) developed between 1996 and 2010 and the policy adopted by Brazilian medical journals were analyzed. Articles were selected on the SciELO Brazil data basis, and the evaluation of ethical aspects was based on the normative contents about ethics in research involving human experimentation according to the Brazilian resolution of the National Health Council no. 196/1996. The editorial policies of the section "Instructions to authors" were analyzed. In the period of 1996-2012, 58.9% of articles involving human Chagas disease did not refer to the fulfillment of the ethical aspects concerning research with human beings. In 80% of the journals, the requirements and confirmation of the information about ethical aspects in the studies of human CD were not observed. Although a failure in this type of service is still observed, awareness has been raised in federal agencies, educational institutions/research and publishing groups to standardize the procedures and ethical requirements for the Brazilian journals, reinforcing the fulfillment of the ethical parameters, according to the resolution of NHC no. 196/1996.

Foram analisados os aspectos éticos das publicações brasileiras sobre a doença de Chagas humana desenvolvidas entre 1996 e 2010 e avaliadas as políticas editoriais dos periódicos médicos brasileiros sobre ética em pesquisa. Os artigos foram selecionados do banco de dados da SciELO Brasil. A avaliação dos aspectos éticos foi baseada nos conteúdos normativos sobre ética envolvendo pesquisa com seres humanos, conforme Resolução brasileira do Conselho Nacional de Saúde - CNS 196/1996. A política editorial dos periódicos foi analisada utilizando-se a seção "Instrução aos autores". No período de 1996-2012, 58,9% dos estudos envolvendo DC humana não informaram no texto sobre o cumprimento dos aspectos éticos, em relação à pesquisa com seres humanos. Em 80% dos periódicos avaliados o requerimento e confirmação das informações sobre os aspectos éticos nos estudos sobre a DC humana não foram observados. Apesar de haver ainda lacunas nesse tipo de citação conforme foi observado, tem-se verificado uma conscientização pelos órgãos federais, instituições de ensino/pesquisa e grupos editoriais para padronizar os procedimentos e orientações éticas por parte dos periódicos brasileiros, reforçando o cumprimento dos pressupostos éticos preconizados pela resolução CNS 196/1996.

Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease

Trypanosoma cruzi infection induces progressive cardiac inflammation that leads to fibrosis and modifications in the heart architecture and functionality. Statins, such as 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, have been studied due to their pleiotropic roles in modulating the inflammatory response. Our goal was to evaluate the effects of simvastatin on the cardiac inflammatory process using a cardiotropic strain of T. cruzi in a murine model of Chagas cardiomyopathy. C57BL/6 mice were infected with 500 trypomastigotes of the Colombian strain of T. cruzi and treated with an oral dose of simvastatin (20 mg/Kg/day) for one month and inflammatory and morphometric parameters were subsequently evaluated in the serum and in the heart, respectively. Simvastatin reduced the total cholesterol and inflammatory mediators (interferon-gamma, tumour necrosis factor-alpha, CCL2 and CCL5) in the serum and in the heart tissue at 30 days post-infection. Additionally, a proportional reduction in heart weight and inflammatory infiltration was observed. Simvastatin also reduced epimastigote proliferation in a dose-dependent manner in vitro and was able to reduce blood trypomastigotes and heart amastigote nests during the acute phase of Chagas disease in vivo. Based on these data, we conclude that simvastatin exerts a modulatory effect on the inflammatory mediators that are elicited by the Colombian strain of T. cruzi and ameliorates the heart damage that is observed in a murine model of Chagas disease.

Uso de fluorescência em um método de dissector modificado para estimar o número de miócitos no tecido cardíaco / Use of fluorescence in a modified disector method to estimate the number of myocytes in cardiac tissue / Uso de fluorescencia en un método de disector modificado para estimar el número de miocitos en el tejido cardíaco

FUNDAMENTO: Métodos convencionais de dissector atualmente requerem consideráveis custos financeiros, técnicos e operacionais para estimar o número de células, incluindo cardiomiócitos, em uma área de 3D. OBJETIVO: Usar a microscopia de fluorescência em um método de dissector modificado para determinar o número de miócitos no tecido cardíaco em condições normais e patológicas. MÉTODOS: O estudo empregou camundongos Wistar machos com quatro meses de idade e peso de 366,25 ± 88,21 g randomizados em grupos controles (GC, n = 8) e infectados (GI, n = 8). Os animais do GI foram inoculados com cepa Y de T. cruzi (300.000 tripomastigotas/50 g). Após oito semanas, os animais foram pesados e sacrificados. Os Ventrículos Esquerdos (VE) foram removidos para análise estereológica da densidade numérica de cardiomiócitos (Nv [c]) e o número total dessas células no VE (N [c]). Esses parâmetros foram estimados usando um dissector fluorescente (DF) e comparados com os métodos convencionais de dissector óptico (DO) e dissector físico (DFi). RESULTADOS: Em ambos os métodos de dissector, os animais do GI apresentaram queda significativa de Nv[c] e N[c] em comparação com os animais do GC (P > 0,05). Uma correlação forte, igual ou superior a 96%, foi obtida entre DF, DO e DFi. CONCLUSÃO: O método DF parece ser igualmente confiável para determinar Nv[c] e N[c] em condições normais e patológicas, apresentando algumas vantagens em relação aos métodos convencionais de dissector: redução de cortes histológicos e imagens na análise estereológica, redução do tempo de análise das imagens, a construção de DF em microscópios simples, utilizando o modo de epifluorescência, distinção de planos de dissector em ampliações inferiores.

BACKGROUND: Conventional disector methods currently require considerable financial, technical and operational costs to estimate the number of cells, including cardyomyocytes, in a 3D area. OBJECTIVE: To use fluorescence microscopy in a modified disector method to determine the number of myocytes in cardiac tissue in normal and pathological conditions. METHODS: The study employed four-month-old male Wistar rats with weight of 366.25 ± 88.21g randomized in control (CG, n=8) and infected (IG, n=8) groups. IG animals were inoculated with T. cruzi Y strain (300,000 trypomastigotes/50g wt). After eight weeks, the animals were weighted and euthanized. The left ventricles (LV) were removed for stereological analysis of numerical density of cardiomyocytes (Nv[c]) and total number of these cells in the LV (N[c]). These parameters were estimated using a fluorescent disector (FD) and compared with the conventional optical (OD) and physical (PD) disector methods. RESULTS: In both disector methods, IG animals presented significant decrease of Nv[c] and N[c] compared to CG animals (P< 0.05). There was no significant difference in these variables despite the disector method applied in CG and IG animals (P> 0.05). A strong correlation, equal or above 96%, was obtained between FD, OD and PD. CONCLUSION: The FD method seems to be equally reliable to determine Nv[c] and N[c] in normal and pathological conditions and presents some advantages compared to conventional disector methods: reduction of histological slices and images in the stereological analysis, reduction of time to analyze the images, construction of FD in simple microscopes using the epifluorescence mode, distinction of disector planes in lower magnifications.

FUNDAMENTO: Métodos convencionales de disector actualmente requieren considerables costos financieros, técnicos y operativos para estimar el número de células, incluyendo cardiomiocitos, en un área de 3D. OBJETIVO: Usar la microscopia de fluorescencia en un método de disector modificado para determinar el número de miocitos en el tejido cardíaco en condiciones normales y patológicas. MÉTODOS: El estudio empleó ratones Wistar machos de cuatro meses de edad y peso de 366,25 ± 88,21 g randomizados en grupos controles (GC, n = 8) e infectados (GI, n = 8). Los animales del GI fueron inoculados con cepa Y de T. cruzi (300.000 tripomastigotas/50 g). Después de ocho semanas, los animales fueron pesados y sacrificados. Los Ventrículos Izquierdos (VI) fueron removidos para análisis estereológico de la densidad numérica de cardiomiocitos (Nv [c]) y el número total de esas células en el VI (N [c]). Esos parámetros fueron estimados usando un disector fluorescente (FD) y comparados con los métodos convencionales de disector óptico (OD) y disector físico (PD). RESULTADOS: En ambos métodos de disector, los animales del GI presentaron caída significativa de Nv[c] y N[c] en comparación con los animales del GC (P > 0,05). Una correlación fuerte, igual o superior a 96%, fue obtenida entre FD, OD y PD. CONCLUSIÓN: El método FD parece ser igualmente confiable para determinar Nv[c] y N[c] en condiciones normales y patológicas, presentando algunas ventajas en relación a los métodos convencionales de disector: reducción de cortes histológicos e imágenes en el análisis estereológico, reducción del tiempo de análisis de las imágenes, la construcción de FD en microscopios simples, utilizando el modo de epifluorescencia, distinción de planos de disector en ampliaciones inferiores.

Ética na publicação de pesquisas sobre leishmaniose visceral humana em periódicos nacionais / Ética en la publicación de investigaciones sobre leishmaniasis visceral humana en periódicos brasileños / Ethics in the publication of studies on human visceral leishmaniasis in Brazilian periodicals

OBJETIVO: Analisar os aspectos éticos dos artigos nacionais sobre leishmaniose visceral humana publicados após a Resolução CNS 196/1996 e analisar a política de periódicos brasileiros sobre ética em pesquisa. MÉTODOS: Estudo exploratório de natureza bibliográfica e documental. A seleção das publicações sobre pesquisas envolvendo seres humanos foi realizada na base SciELO Brasil a partir de 1996. Foram analisadas lacunas relacionadas às políticas editoriais dos periódicos médicos a partir de informações obtidas da seção "Instruções aos autores" de cada periódico. RESULTADOS: Observou-se que, enquanto no primeiro quadriênio (1997 a 2000) nenhum artigo mencionou o cumprimento dos aspectos éticos, no ano de 2009 do quadriênio (2009 a 2012), 75 por cento cumpriram pelo menos uma das orientações éticas avaliadas. Seis em 11 periódicos indicaram que as informações sobre os aspectos éticos deveriam ser citadas no corpo do artigo. Três periódicos fizeram exigências quanto ao envio de carta ou documento assinado pelo(s) autor(es) informando o cumprimento dos aspectos; dois solicitaram cópia do documento de obtenção do termo de consentimento livre e esclarecido; um explicitou a necessidade do envio de cópia da autorização da aprovação pelo comitê de ética em pesquisa; e em quatro periódicos analisados não foi identificada nenhuma exigência sobre aspectos éticos. CONCLUSÕES: Houve melhora em relação à descrição do cumprimento dos aspectos éticos nos artigos. Sugere-se a padronização das orientações éticas relacionadas à pesquisa com seres humanos nos periódicos nacionais. Isso pode estimular o cumprimento dos pressupostos de documentos que regem a experimentação humana.

OBJETIVO: Analizar los aspectos éticos de los artículos nacionales sobre leishmaniasis visceral humana publicados posterior a la Resolución CNS 196/1996 (Brasil) y analizar la política de periódicos brasileños sobre ética en investigación.MÉTODOS: Estudio exploratorio de naturaleza bibliográfica y documental. La selección de las publicaciones sobre investigaciones envolviendo seres humanos fue realizada en la base SciELO Brasil a partir de 1996. Fueron analizadas lagunas relacionadas con las políticas editoriales de los periódicos médicos a partir de informaciones obtenidas de la sección "Instrucciones a los autores" de cada periódico.RESULTADOS: Se observó que mientras en el primer cuatrienio (1997 a 2000) ningún artículo mencionó el cumplimiento de los aspectos éticos, en el año 2009 del cuatrienio (2009 a 2012), 75% cumplieron por lo menos una de las orientaciones éticas evaluadas. Seis en 11 periódicos indicaron que las informaciones sobre los aspectos éticos deberían ser citadas en el cuerpo del artículo. Tres periódicos hicieron exigencias con relación al envío de carta o documento firmado por el(los) autor(es) informando el cumplimiento de los aspectos; dos solicitaron copia del documento de obtención del termo de consentimiento libre e esclarecido; uno dejó explicita la necesidad de envío de copia de la autorización de la aprobación por el comité de ética en pesquisa y en cuatro periódicos analizados no fue identificada ninguna exigencia sobre aspectos éticos.CONCLUSIONES: Hubo mejoría con relación a la descripción del cumplimiento de los aspectos éticos en los artículos. Se sugiere la estandarización de las orientaciones éticas relacionadas con la investigación con seres humanos en los periódicos brasileños. Esto puede estimular el cumplimiento de las suposiciones de documentos que rigen la experimentación humana.

The ethical issues of research involving human beings contained in the editorial guidelines of Brazilian medical journals / Os aspectos éticos das pesquisas envolvendo seres humanos contidos nas diretrizes editoriais das revistas médicas brasileiras

The present study aimed to analyze the ethical aspects contained in the sections Instructions to authors of Brazilian medical journals which were highly qualified on the assessment of the Qualis program of Conselho Técnico Científico da Educação Superior (CTC-ES) (Medicine I area - reference year 2007). Moreover, we searched in the journals that present information about the ethical issues involved in research with humans, if these journals inform the authors about how they should confirm to the editors the compliance with ethical issues of their studies. The editorial guidelines of 34 journals (17.6%, B2 score; 35.3% B3 score; 47.1% B4 score) were analyzed. It was observed that only 7 (20.6%) journals do no mention some ethical questions related to research involving human subjects and that 25 (73.5%) journals indicate the need for approval of research by Ethics Committee of the institution where the study was conducted. However, less than half (44.1%) of the journals clearly indicate in their Instructions to authors that information about the ethical aspects of research involving human subjects should be cited in the text of the manuscript submitted. Thus, further improvement is still necessary regarding the approach of ethical issues in the editorial guidelines of the Brazilian medical journals analyzed. Researches like this seek to contribute with the discussion about the awareness of editors, so that they mention in the instructions of their journals the principles, rules and ethical standards that must be considered in the research involving human beings.

O presente estudo teve por objetivo analisar os aspectos éticos contidos na seção Instruções aos autores dos periódicos médicos brasileiros mais bem conceituados na avaliação do Qualis de Periódicos do Conselho Técnico Científico da Educação Superior (CTC-ES) (Área Medicina I ano base 2007). Além disso, buscou investigar nos periódicos que disponibilizam alguma informação sobre as questões éticas envolvidas na experimentação em seres humanos, se os mesmos informam aos autores a maneira com que eles devem confirmar aos editores o cumprimento das questões éticas dos seus estudos. As diretrizes editoriais de 34 periódicos (17,6%, conceito B2; 35,3% conceito B3; 47,1% conceito B4) foram analisadas. Foi observado que apenas 7 (20,6%) dos periódicos analisados não mencionaram alguma questão ética relacionada à pesquisa envolvendo seres humanos e que 25 (73,5%) deles indicam a necessidade de aprovação da pesquisa pelo Comitê de Ética da instituição onde o estudo foi conduzido. Contudo, menos da metade (44,1%) dos periódicos analisados deixaram claro em suas Instruções aos Autores que informações sobre os aspetos éticos da pesquisa com seres humanos devem ser citados no corpo do manuscrito. Assim, concluiu-se que ainda são necessárias maiores melhorias quanto à abordagem das questões éticas nas diretrizes editoriais dos periódicos médicos brasileiros analisados. Pesquisas como esta visam a contribuir com a discussão sobre a conscientização dos editores para que façam constar nas instruções dos seus periódicos os princípios, normas e padrões éticos que devem ser obedecidos na pesquisa envolvendo seres humanos.

In vitro and in vivo experimental models for drug screening and development for Chagas disease

Chagas disease, a neglected illness, affects nearly 12-14 million people in endemic areas of Latin America. Although the occurrence of acute cases sharply has declined due to Southern Cone Initiative efforts to control vector transmission, there still remain serious challenges, including the maintenance of sustainable public policies for Chagas disease control and the urgent need for better drugs to treat chagasic patients. Since the introduction of benznidazole and nifurtimox approximately 40 years ago, many natural and synthetic compounds have been assayed against Trypanosoma cruzi, yet only a few compounds have advanced to clinical trials. This reflects, at least in part, the lack of consensus regarding appropriate in vitro and in vivo screening protocols as well as the lack of biomarkers for treating parasitaemia. The development of more effective drugs requires (i) the identification and validation of parasite targets, (ii) compounds to be screened against the targets or the whole parasite and (iii) a panel of minimum standardised procedures to advance leading compounds to clinical trials. This third aim was the topic of the workshop entitled Experimental Models in Drug Screening and Development for Chagas Disease, held in Rio de Janeiro, Brazil, on the 25th and 26th of November 2008 by the Fiocruz Program for Research and Technological Development on Chagas Disease and Drugs for Neglected Diseases Initiative. During the meeting, the minimum steps, requirements and decision gates for the determination of the efficacy of novel drugs for T. cruzi control were evaluated by interdisciplinary experts and an in vitro and in vivo flowchart was designed to serve as a general and standardised protocol for screening potential drugs for the treatment of Chagas disease.

Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy

Global left ventricular (LV) systolic dysfunction is the strongest predictor of morbidity and mortality in Chagas disease. Echocardiography is considered the gold standard for the detection of LV dysfunction, but not always available in endemic areas where chagasic cardiomyopathy is most common. Brain natriuretic peptide (BNP) is a neurohormone that has been recently described as a simple and inexpensive diagnostic and prognostic marker for patients with congestive heart failure. Chagasic patients (n = 63) and non-infected healthy individuals (n = 18) were recruited prospectively and underwent complete clinical examination, echocardiography and 24-h Holter monitoring. BNP was measured from thawed plasma samples using the Triage BNP test. We observed high levels of BNP in association with depression of LV ejection fraction, with increase of LV end-diastolic diameter and with LV premature complexes. An elevated concentration of BNP, defined as a concentration of 60 pg/ml or more, had a sensitivity of 91.7 percent, specificity of 82.8 percent, positive predictive value of 52.4 percent, and negative predictive value of 98 percent for detecting LV dysfunction (LV ejection fraction < 40 percent).BNP measurement using a simple, relatively inexpensive and rapid test has a promising role in identifying LV dysfunction associated with chagasic cardiomyopathy. Equally important, patients with Trypanosoma cruzi infection who have low levels of BNP level in plasma have a very low likelihood of severe cardiac involvement, and echocardiography is probably not necessary.